UBS Group
BDMDW icon

UBS Group’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

UBS Group’s Portfolio BDMDW Stock Details BDMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01K Sell
22,371
-25,825
-54% -$1.06K ﹤0.01% 10397
2026
Q2 		$1.93K Hold
48,196
– – ﹤0.01% 9443
2026
Q1 		$3.86K Hold
48,196
– – ﹤0.01% 9021
2025
Q4 		$2.46K Sell
48,196
-1,327
-3% -$80 ﹤0.01% 9304
2025
Q3 		$3.22K Hold
49,523
– – ﹤0.01% 9071
2025
Q2 		$3.96K Sell
49,523
-864
-2% -$60 ﹤0.01% 9304
2025
Q1 		$3.78K Buy
50,387
+2,191
+5% +$228 ﹤0.01% 9179
2024
Q4 		$9.9K Buy
+48,196
New +$1.91K ﹤0.01% 8333

Other funds holding BDMDW

Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $14.8M AUM 14.32% 1-Year Est. Return

UBS Group's BDMDW Position: Q3 2026 in Review

UBS Group reduced its Baird Medical Investment Holdings Warrant (BDMDW) stake by 54% in Q3 2026, selling an estimated $1.06K and leaving 22,371 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #10397.

UBS Group first reported a position in BDMDW in Q4 2024 and has held it in 8 quarters since. The position peaked at $9.9K in Q4 2024. 5 funds tracked by Wall St. Rank hold BDMDW as of Q3 2026.

  • UBS Group held 22,371 shares of Baird Medical Investment Holdings Warrant worth $1.01K as of Q3 2026.
  • UBS Group sold 25,825 Baird Medical Investment Holdings Warrant shares in Q3 2026, an estimated $1.06K.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10397 holding.
  • UBS Group first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 8 quarters since.
  • UBS Group's Baird Medical Investment Holdings Warrant position peaked at $9.9K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.